top of page
3.0_Header_OPT2.png

INTENDED FOR U.S. AUDIENCES ONLY

REMI logo

EPITEL™: REVOLUTIONIZING 
HOW BRAIN HEALTH IS MONITORED

Epitel is a digital health company modernizing brain health solutions to improve seizure monitoring and detection. By leveraging our proprietary cloud-based wearable sensor system and other innovative AI technologies, we are empowering better treatment decisions by making EEG readily deployable and accessible. We are headquartered in Salt Lake City.

We’ve developed a wearable, wireless EEG monitoring platform to provide accessible, affordable, and reliable electrographic seizure detection. Epitel received FDA clearance for its first product, known as REMI™ Remote EEG Monitoring System, in 2021.

MEET OUR TEAM

We are a diversely talented team with expertise in medical devices, big data analytics, and computational neuroscience.

Mark Lehmkuhle, PhD Profile_2x.jpg

Neural Engineer, entrepreneur, 
25+ years neural engineering, epilepsy, and signal processing

MARK LEHMKUHLE, PhD

CEO/CTO, Founder

Matt Parrott Headshot
MATT PARROTT

VP of R&D and Manufacturing

25+ years in global product development, engineering, and manufacturing for medical hardware

new-chris-phillips.jpg
CHRIS PHILLIPS

VP of Regulatory and Quality

20+ years in medical device regulatory, quality, and clinical affairs

Mitch Frankel, PhD Profile_2x.jpg
MITCH FRANKEL, PhD

Senior Computational Scientist

15+ years in neural and biorobotic engineering as well as biomedical device development and testing

Rob Lingstuyl Headshot
ROB LINGSTUYL

Software Architect

20+ years in multiplatform software application development

Jackie Dorsky Headshot
JACKIE DORSKY

VP of Marketing

15+ years in healthcare marketing, leading dynamic teams and medical device launches

james-landis.jpg
JAMES LANDIS

VP of Sales and Commercialization

18+ years in healthcare sales, specializing in the commercialization 
of innovative products

Mark Foran-image.jpg
MARK FORAN

Senior Director 
of Medical Affairs

18+ years in medical affairs and healthcare leadership

Michael Elwood Headshot
MICHAEL ELWOOD

Electrical Engineer

25+ years developing medical devices

REMI SYSTEM SAFETY INFORMATION

INDICATIONS
REMI Remote EEG Monitoring System Indications for Use

The REMI Remote EEG Monitoring System is indicated for use in healthcare settings where near real-time and/or remote EEG is warranted and in ambulatory settings where remote EEG is warranted. REMI uses single use, single patient, disposable, wearable sensors intended to amplify, capture, and wirelessly transmit a single channel of electrical activity of the brain for a duration up to 30 days.

The REMI System uses the REMI Mobile software application that runs on qualified commercial off-the-shelf mobile computing platforms. REMI Mobile displays user setup information to trained medical professionals and provides notifications to medical professionals and ambulatory users. REMI Mobile receives and transmits data from connected REMI Sensors to the secure REMI Cloud where it is stored and prepared for review on qualified EEG viewing software.

REMI does not make any diagnostic conclusion about the subject’s condition and is intended as a physiological signal monitor. The REMI System is indicated for use with adult and pediatric patients (6+ years).

Please click here for full Instructions for Use for REMI™ Healthcare Facility and REMI™ Ambulatory.

REMI Vigilenz AI For Event Detection Indications for Use 

REMI Vigilenz AI For Event Detection is indicated for the analysis of REMI Remote EEG Monitoring System electroencephalogram (EEG) recordings. REMI Vigilenz AI For Event Detection is intended to be used by physicians qualified to analyze and interpret EEG who will exercise professional judgment in using the information. 

As an aide to the qualified physician’s REMI EEG review, REMI Vigilenz AI For Event Detection marks previously acquired sections of REMI EEG that may correspond to neurological events of interest indicative of potential electrographic seizures lasting at least 10 seconds in duration. REMI Vigilenz AI For Event Detection is indicated for use with adult and pediatric patients (6+ years). 

REMI Vigilenz AI For Event Detection does not mark REMI EEG records in real time and does not provide any diagnostic conclusion about the patient’s condition to the user.

Please click here for full Instructions for Use for REMI Vigilenz™ AI for Event Detection.

ISI
EPITEL logo

465 S. 400 E
Suite 250
Salt Lake City, UT 84111
801-497-6297
info@epitel.com

© 2024 BY EPITEL

All rights reserved. Epitel, REMI, and REMI Vigilenz AI are trademarks of Epitel, Inc.
All other trademarks are the property of their respective owners. 

For technical and customer support, please call: 

801-497-6297

bottom of page